{
    "organizations": [],
    "uuid": "082323c1aa3a51699efceede442930081b6e8096",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-index-pharmaceuticals-q4-operating/brief-index-pharmaceuticals-q4-operating-loss-widens-to-sek-22-6-mln-idUSFWN1QF02O",
    "ord_in_thread": 0,
    "title": "BRIEF-Index Pharmaceuticals Q4 Operating Loss Widens To SEK ‍22.6​ Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Index Pharmaceuticals Holding Ab :\n* Q4 REVENUE SEK ‍0​ VERSUS SEK 0.3 MILLION YEAR AGO * Q4 OPERATING LOSS SEK ‍22.6​ MILLION VERSUS LOSS SEK 16.4 MILLION YEAR AGO\n* THE BOARD WILL NOT PROPOSE A DIVIDEND FOR 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-26T15:07:00.000+02:00",
    "crawled": "2018-02-27T14:40:47.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "index",
        "pharmaceutical",
        "holding",
        "ab",
        "q4",
        "revenue",
        "sek",
        "versus",
        "sek",
        "million",
        "year",
        "ago",
        "q4",
        "operating",
        "loss",
        "sek",
        "million",
        "versus",
        "loss",
        "sek",
        "million",
        "year",
        "ago",
        "board",
        "propose",
        "dividend",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}